In ovarian cancer, PD-1+ NK cells exhibit low proliferative responses and impaired antitumor activities when interacting with tumor cells, which can be partially restored by blocking the PD-1/PD-L1 interaction43. The gene discussed is PDCD1; the disease is neoplasm.